Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21657784 | 0.88 | — | — | |
| SCHEMBL15561070 | 0.77 | MEN1 (0.33) | TSHR | |
| SCHEMBL7770560 | 0.77 | FDPS (0.32) | — | |
| SCHEMBL1467767 | 0.75 | — | — | |
| SCHEMBL349145 | 0.75 | TSHR (0.30) | TSHR | |
| SCHEMBL2481172 | 0.73 | — | — | |
| Iodide SCHEMBL5092921 | 0.73 | — | — | |
| Bromide SCHEMBL5085164 | 0.73 | — | — | |
| SCHEMBL20083611 | 0.73 | — | — | |
| Water SCHEMBL1886264 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105503946-A | Method for making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom | ICL-IP America Inc | 2016-04-20 | — | — | CN | claimed |
| CN-102256987-B | Hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foams, and methods of making articles made therefrom | ICL-IP AMERICA INC. (US) | 2016-01-13 | — | — | CN | claimed |
| US-9187504-B2 | Method of making hydroxymethylphosphonate | ICL-IP AMERICA INC. (US) | 2015-11-17 | — | — | US | claimed |
| EP-2376507-B1 | METHOD OF MAKING HYDROXYMETHYLPHOSPHONATES | ICL IP AMERICA INC (US) | 2013-05-15 | — | — | EP | claimed |
| US-8198341-B2 | Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom | ICL-IP AMERICA INC. (US) | 2012-06-12 | — | — | US | claimed |
| US-20110257287-A1 | Method of Making Hydroxymethylphosphonate, Polyurethane Foam-Forming Compositions, Polyurethane Foam and Articles Made Therefrom | STOWELL JEFFREY K | 2011-10-20 | — | — | US | claimed |
| EP-2376507-A1 | METHOD OF MAKING HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS POLYURETHANE FOAM AND ARTICLES MADE THEREFORM | ICL-IP America Inc. (US) | 2011-10-19 | — | — | EP | claimed |
| WO-2010080425-A1 | METHOD OF MAKING HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS POLYURETHANE FOAM AND ARTICLES MADE THEREFORM | SUPRESTA LLC. (US) | 2010-07-15 | — | — | WO | claimed |
| US-20100160468-A1 | Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom | ICL-IP AMERICA INC. | 2010-06-24 | — | — | US | claimed |
| EP-3553068-B1 | YDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS, POLYURETHANE FOAM AND ARTICLES MADE THEREFROM | ICL IP AMERICA INC (US) | 2021-04-28 | — | — | EP | disclosed |
| EP-3553068-A1 | HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS, POLYURETHANE FOAM AND ARTICLES MADE THEREFROM | ICL-IP America Inc. (US) | 2019-10-16 | — | — | EP | disclosed |
| EP-2909218-B1 | METHOD OF MAKING HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS, POLYURETHANE FOAM AND ARTICLES MADE THEREFROM | ICL IP AMERICA INC (US) | 2019-07-10 | — | — | EP | disclosed |
| US-9657151-B1 | Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom | ICL-IP AMERICA INC. (US) | 2017-05-23 | — | — | US | disclosed |
| US-20170137590-A1 | METHOD OF MAKING HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS, POLYURETHANE FOAM AND ARTICLES MADE THEREFROM | ICL-IP America Inc (US) | 2017-05-18 | — | — | US | disclosed |
| EP-2376507-A1 | METHOD OF MAKING HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS POLYURETHANE FOAM AND ARTICLES MADE THEREFORM | ICL-IP America Inc. (US) | 2011-10-19 | — | — | EP | disclosed |
| WO-2010080425-A1 | METHOD OF MAKING HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS POLYURETHANE FOAM AND ARTICLES MADE THEREFORM | SUPRESTA LLC. (US) | 2010-07-15 | — | — | WO | disclosed |
| US-20100160468-A1 | Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom | ICL-IP AMERICA INC. | 2010-06-24 | — | — | US | disclosed |
| EP-0838508-B1 | Aqueous ink composition for use in an ink-jet printer | SEIKO EPSON CORP (JP) | 2001-08-29 | — | — | EP | disclosed |
| US-5871572-A | COLORANT, WATER, A WATER-SOLUBLE ORGANIC SOLVENT, AND PECTIC ACID | SEIKO EPSON CORPORATION (JP) | 1999-02-16 | — | — | US | disclosed |
| EP-0838508-A2 | Aqueous ink composition for use in an ink-jet printer | SEIKO EPSON CORPORATION (JP) | 1998-04-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110257287-A1 | Method of Making Hydroxymethylphosphonate, Polyurethane Foam-Forming Compositions, Polyurethane Foam and Articles Made Therefrom | PFAS, PGM2, NEFM | TSHR 3999/4885 |
| US-20100160468-A1 | Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom | PFAS, PGM2, NEFM | TSHR 3999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.